The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Open accessAbstract
BACKGROUND: HMG CoA reductase inhibitors (or statins), a new class of lipid-lowering compounds, have raised expectations for more widespread use than that of the older lipid-lowering drugs. Not only are they more effective in lowering LDL cholesterol, but they are better tolerated as well. No data exist concerning the effect of statins on early carotid atherosclerosis and clinical events in men and women who have moderately elevated LDL cholesterol levels but are free of symptomatic cardiovascular disease. METHODS AND RESULTS: Lovastatin (20 to 40 mg/d) or its placebo was evaluated in a double-blind, randomized clinical trial with factorial design along with warfarin (1 mg/d) or its placebo. This report is limited to the lovastatin component of the trial. Daily aspirin (81 mg/d) was recommended for everyone. Enrollment included 919 asymptomatic men and women, 40 to 79 years old, with early carotid atherosclerosis as defined by B-mode ultrasonography and LDL cholesterol between the 60th and 90th percentiles. The 3-year change in mean maximum intimal-medial thickness (IMT) in 12 walls of the carotid arteries was the primary outcome; change in single maximum IMT and incidence of major cardiovascular events were secondary outcomes. LDL cholesterol fell 28%, from 156.6 mg/dL at baseline to 113.1 mg/dL at 6 months (P < .0001), in the lovastatin groups and was largely unchanged in the lovastatin-placebo groups. Among participants not on warfarin, regression of the mean maximum IMT was seen after 12 months in the lovastatin group compared with the placebo group; the 3-year difference was statistically significant (P = .001). A larger favorable effect of lovastatin was observed for the change in single maximum IMT but was not statistically significant (P = .12). Five lovastatin-treated participants suffered major cardiovascular events--coronary heart disease mortality, nonfatal myocardial infarction, or stroke--versus 14 in the lovastatin-placebo groups (P = .04). One lovastatin-treated participant died, compared with eight on lovastatin-placebo (P = .02). CONCLUSIONS: In men and women with moderately elevated LDL cholesterol, lovastatin reverses progression of IMT in the carotid arteries and appears to reduce the risk of major cardiovascular events and mortality. Results from ongoing large-scale clinical trials may further establish the clinical benefit of statins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citationGoodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,246
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Transformation and Weighting in Regression
Carroll, R. J., & Ruppert, D. (1988) · Springer eBooks · doi:10.1007/978-1-4899-2873-3 · Cited by 1,299
Heiss, G., Sharrett, A. R., Barnes, R., Chambless, L. E., Szklo, M., & Alzola, C. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116078 · Cited by 839
Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Salonen, R., & Salonen, J. T. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90056-o · Cited by 445
Cholesterol lowering and mortality: the importance of considering initial level of risk.
Smith, G. D., Song, F., & Sheldon, T. A. (1993) · BMJ · doi:10.1136/bmj.306.6889.1367 · Cited by 423
Blankenhorn, D. H., Selzer, R. H., Crawford, D. W., Barth, J. D., Liu, C. R., Liu, C. H., Mack, W. J., & Alaupovic, P. (1993) · Circulation · doi:10.1161/01.cir.88.1.20 · Cited by 384
Bradford, R. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010067008 · Cited by 372
Prognostic significance of progression of coronary atherosclerosis.
Waters, D., Craven, T. E., & Lespérance, J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1067 · Cited by 277
Holme, I. (1990) · Circulation · doi:10.1161/01.cir.82.6.1916 · Cited by 240
(1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90858-a · Cited by 182
Changes in Sequential Coronary Arteriograms and Subsequent Coronary Events
Buchwald, H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110067031 · Cited by 168
Shear, C. L., Franklin, F. A., Stinnett, S. S., Hurley, D. P., Bradford, R. H., Chremos, A. N., Nash, D. T., & Langendörfer, A. (1992) · Circulation · doi:10.1161/01.cir.85.4.1293 · Cited by 82
Pravastatin, lipids, and major coronary events
Furberg, C. D., Byington, R. P., Crouse, J. R., & Espeland, M. A. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90297-6 · Cited by 79
Self-citationFactorial designs in clinical trials: The effects of non‐compliance and subadditivity
Brittain, E., & Wittes, J. T. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080204 · Cited by 68
Cholesterol lowering as a treatment for established coronary heart disease.
LaRosa, J. C., & Cleeman, J. I. (1992) · Circulation · doi:10.1161/01.cir.85.3.1229 · Cited by 65
Rationale and design for the asymptomatic carotid artery plaque study (ACAPS)
The ACAPS Group (1992) · Controlled Clinical Trials · doi:10.1016/0197-2456(92)90012-o · Cited by 57
Lessons learned from clinical trials with ultrasound end‐points
Furberg, C. D., Byington, R. P., & Craven, T. E. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00848.x · Cited by 53
Self-citationAnalysis strategies for serial multivariate ultrasonographic data that are incomplete
Espeland, M. A., Byington, R. P., Hire, D., Davis, V. G., Hartwell, T., & Probstfield, J. L. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110806 · Cited by 47
Self-citation
Cited by
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A., & Grobbee, D. E. (1997) · Circulation · doi:10.1161/01.cir.96.5.1432 · Cited by 2,345
Metadata
- Authors
- Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A.
- Venue
- Circulation
- Published
- 1994-10
- Volume
- 90
- Issue
- 4
- Pages
- 1679-1687
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1965408926
- Cited by
- 867
- References
- 25
- FWCI
- 41.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.